You have 9 free searches left this month | for more free features.

Late acute Graft-versus-Host Disease

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Myeloid Hematologic Malignancy, Lymphoid Hematologic Malignancy Trial in New York (Ixazomib)

Completed
  • Myeloid Hematologic Malignancy
  • Lymphoid Hematologic Malignancy
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Sep 3, 2021

Chronic Graft-versus-Host-Disease, Allogeneic Hematopoietic Stem Cell Transplantation, Leukemia Trial

Not yet recruiting
  • Chronic Graft-versus-Host-Disease
  • +4 more
    • (no location specified)
    Jan 11, 2023

    Steroid-refractory Acute Graft-versus-Host Disease, Treatment-refractory Acute Graft-versus-Host Disease Trial in United States

    Completed
    • Steroid-refractory Acute Graft-versus-Host Disease
    • Treatment-refractory Acute Graft-versus-Host Disease
    • Neihulizumab (ALTB-168)
    • Duarte, California
    • +12 more
    Jan 17, 2023

    Steroid-refractory Acute Graft-versus-host Disease Trial (MC0518, BAT)

    Not yet recruiting
    • Steroid-refractory Acute Graft-versus-host Disease
    • MC0518
    • BAT
    • (no location specified)
    Oct 4, 2023

    Acute GVHD, Hematopoietic and Lymphoid System Tumor Trial in Seattle (Fecal Microbiota Transplantation Capsule, Placebo)

    Not yet recruiting
    • Acute Graft Versus Host Disease
    • Hematopoietic and Lymphoid System Neoplasm
    • Fecal Microbiota Transplantation Capsule
    • Placebo
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Sep 6, 2023

    Acute GVHD Trial (Itolizumab, Methylprednisolone)

    Not yet recruiting
    • Acute Graft Versus Host Disease
    • (no location specified)
    Apr 10, 2023

    Acute GVHD, Hematopoietic and Lymphoid System Tumor Trial in Duarte (Cholestyramine, Leflunomide, Steroid Therapy)

    Recruiting
    • Acute Graft Versus Host Disease
    • Hematopoietic and Lymphoid System Neoplasm
    • Duarte, California
      City of Hope Medical Center
    Jan 5, 2023

    Acute GVHD, Gastrointestinal Tract Acute GVHD, Severe Gastrointestinal Tract Acute GVHD Trial in Los Angeles (Fecal Microbiota

    Not yet recruiting
    • Acute Graft Versus Host Disease
    • +3 more
    • Fecal Microbiota Transplantation Capsule
    • Los Angeles, California
      UCLA / Jonsson Comprehensive Cancer Center
    Sep 16, 2022

    Graft-versus-host-disease, CMV Trial (Letermovir)

    Not yet recruiting
    • Graft-versus-host-disease
    • CMV
    • (no location specified)
    Jul 23, 2023

    Acute Graft-versus-host Disease Trial in Duarte (GDC-8264)

    Recruiting
    • Acute Graft-versus-host Disease
    • Duarte, California
      City of Hope National Medical Center
    Jan 12, 2023

    GVHD Trial in Tampa (Cultured Treg cells)

    Completed
    • Graft Versus Host Disease
    • Cultured Treg cells
    • Tampa, Florida
      H Lee Moffitt Cancer Center
    Nov 2, 2022

    Acute Graft Versus Host Disease

    Not yet recruiting
    • GVHD,Acute
    • blood sample
    • Detroit, Michigan
      Henry Ford Health System
    Jan 30, 2023

    Acute GVHD Trial in Kansas City (MSCTC-0010 Dose Escalation)

    Recruiting
    • Acute Graft Versus Host Disease
    • MSCTC-0010 Dose Escalation
    • Kansas City, Kansas
      Kansas University Cancer Center
    Jan 30, 2023

    GVHD, Postbiotics, Butyrate Trial in Seoul (sodium butyrate)

    Recruiting
    • Graft Versus Host Disease
    • +2 more
    • sodium butyrate
    • Seoul, Korea, Republic of
      Soonchunhyang University Seoul Hospital
    Apr 11, 2023

    Transplant-Related Disorder Trial in Tianjin (Ruxolitinib)

    Recruiting
    • Transplant-Related Disorder
    • Tianjin, Tianjin, China
      Institute of Hematology & Blood Diseases Hospital
    Jan 28, 2023

    Graft Vs Host Disease, Acute-graft-versus-host Disease, Chronic Graft-versus-host-disease Trial in Boston (Exercise, Attention

    Recruiting
    • Graft Vs Host Disease
    • +2 more
    • Exercise
    • Attention control
    • Boston, Massachusetts
    • +1 more
    Nov 28, 2022

    Patients at Risk for Chronic Graft-Versus-Host Disease

    Not yet recruiting
    • cGVHD
    • Non-Interventional
    • (no location specified)
    Jun 16, 2023

    Acute Graft-versus-Host Disease

    Active, not recruiting
    • Acute Graft-versus-Host Disease
    • Allogeneic Stem Cell Transplant
    • Blood samples
    • Columbus, Ohio
      Ohio State University Medical Center
    Apr 18, 2022

    Graft Vs Host Disease Trial in Vandoeuvre Les Nancy (Uvadex, Steroids)

    Not yet recruiting
    • Graft Vs Host Disease
    • Vandoeuvre Les Nancy, France
      CHRU de Nancy
    Nov 10, 2023

    Chronic GVHD Trial in United States (drug, procedure, other)

    Not yet recruiting
    • Chronic Graft Versus Host Disease
    • Tampa, Florida
    • +4 more
    Aug 10, 2023

    Transplant-Related Disorder Trial (Ruxolitinib)

    Not yet recruiting
    • Transplant-Related Disorder
    • (no location specified)
    Oct 25, 2022

    Graft Vs Host Disease, Graft-versus-host-disease, GVHD Trial in Saint Louis (Ruxolitinib)

    Not yet recruiting
    • Graft Vs Host Disease
    • +2 more
    • Saint Louis, Missouri
      Washington University School of Medicine
    Aug 18, 2023

    Hematopoietic Stem Cell Transplantation, Acute GVHD, Acute Myeloid Leukemia Trial in United States (CD24Fc, Placebo,

    Terminated
    • Hematopoietic Stem Cell Transplantation
    • +4 more
    • Duarte, California
    • +3 more
    Oct 18, 2022

    Acute-graft-versus-host Disease, Chronic Graft-versus-host-disease, Solid Organ Transplant Trial in Cincinnati (Ruxolitinib)

    Recruiting
    • Acute-graft-versus-host Disease
    • +2 more
    • Cincinnati, Ohio
      Cincinnati Children's Hospital Medical Center
    Mar 31, 2022

    Hematopoietic and Lymphoid Cell Tumor, Steroid Refractory GVHD Trial in Houston (Cellular Therapy, Ruxolitinib)

    Recruiting
    • Hematopoietic and Lymphoid Cell Neoplasm
    • Steroid Refractory Graft Versus Host Disease
    • Houston, Texas
      M D Anderson Cancer Center
    Jul 9, 2022